Results for "didanosina" | Prospecte.ro

Medication leaflets

DIDANOZINA AUROBINDO 250mg gastro-resistant capsules

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription

P-RF
DIDANOZINA AUROBINDO 400mg gastro-resistant capsules

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription

P-RF
VIDEX 100mg dispersible / chewable tablets BRISTOL MYERS SQUIBB ORIGINAL MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription

P-RF
VIDEX 150mg dispersible / chewable tablets BRISTOL MYERS SQUIBB ORIGINAL MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription

P-RF
VIDEX EC 125mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription

P-RF
VIDEX EC 200mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription

P-RF
VIDEX EC 250mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription

P-RF
VIDEX EC 400mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription

P-RF

Results for the substance didanosina

didanosine

Indicated for: HIV-1 infection

J05AF02 Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors